ArticleRespirology case reports2026
EUS-B FNA of Enlarged Left Adrenal Gland in Lung Cancer-Case Series.
Article in Respirology case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- EUS-B FNA of Enlarged Left Adrenal Gland in Lung Cancer-Case Series.Respirology case reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Combined endobronchial and endoscopic ultrasound via bronchoscope (EBUS EUS-B) is an established method for diagnosis, staging and tissue acquisition in lung cancer. With incorporation of EUS-B fine needle aspirate (EUS-B FNA) of enlarged left adrenal gland (LAG), combined EBUS EUS-B can aid in excluding metastatic spread or differentiating between regional (M1a) versus distant (M1b) single organ or multi-organ metastatic disease (M1c). In comparing, EUS FNA of LAG via conventional gastro-echoendoscope with EUS-B, conventional EUS can successfully visualise LAG more frequently. However, once visualization is achieved, outcomes in terms of diagnostic yield and tissue adequacy are comparable. Complication and adverse event rates are low. EUS-B FNA of LAG is aligned with patient-centric benefits of combined EBUS EUS-B. In our case series, we illustrate the use of EUS-B FNA for diagnosis, staging and tissue acquisition in lung cancer. We highlight learning points, discuss risk and benefits and advocate for broader integration into clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.